Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers ≤2 cm

Endocrine-Related Cancer

Volumn 16, Issue 1, 2009, Pages 201-210

  Perrino, Michela ^a   Vannucchi, Guia ^a   Vicentini, Leonardo ^b   Cantoni, Gianmaria ^b   Dazzi, Davide ^a   Colombo, Carla ^a   Rodari, Marcello ^c   Chiti, Arturo ^c   Beck Peccoz, Paolo ^a   Fugazzola, Laura ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ADULT; ARTICLE; CANCER INVASION; CANCER REGRESSION; CANCER SIZE; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAPILLARY THYROID CANCER; PROGNOSIS; RECURRENT CANCER; THYROID CANCER; THYROIDECTOMY; FOLLOW UP; HOSPITALIZATION; LYMPHADENECTOMY; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PAPILLARY CARCINOMA; PATHOLOGY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; THYROID TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; CARCINOMA, PAPILLARY; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 65549124975     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-08-0119     Document Type: Article

References (34)

1. American Joint Committee of Cancer 2002 Cancer staging manual. In AJCC Cancer Staging Handbook, Eds FL Greene, DL Page, ID Fleming, AG Fritz, CM Baclch, DG Heller & M Morrow, edn 6, New York: Springer-Berlag.
2. Arturi F, Russo D, Giuffrida D, Ippolito A, Perrotti N, Vigneri R & Filetti S 1997 Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. Journal of Clinical Endocrinology and Metabolism 82 1638-1641.
3. Baudin E, Travagli JP, Ropers J, Mancusi F, Bruno-Bossio G, Caillou B, Cailleux AF, Lumbroso JD, Parmentier C & Schlumberger M 1998 Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute Experience. Cancer 83 553-559.
4. Besic N, Pilko G, Petric R, Hocevar M & Zgajnar J 2008 Papillary thyroid microcarcinoma: prognostic factors and treatment. Journal of Surgical Oncology 97 221-225.
5. Bramley MD & Harrison BJ 1996 Papillary microcarcinoma of the thyroid gland. British Journal of Surgery 83 1674-1683.
6. Chow SM, Law SC, Chan JK, Au SK, Yau S & Lau WH 2003 Papillary microcarcinoma of the thyroid. Prognostic significance of lymph node metastasis and multifocality. Cancer 98 31-40.
7. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM et al. 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 109-142.
8. Davies L & Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. Journal of the American Medical Association 295 2164-2167.
9. Gimm O, Rath FW & Dralle H 1998 Pattern of lymph node metastases in papillary thyroid carcinoma. British Journal of Surgery 85 252-254.
10. Grant CS, Hay ID, Gough IR, Bergstralh EJ, Goellner JR & McConahey WM 1988 Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery 104 954-962.
11. Harach HR, Franssila KO & Wasenius VM 1985 Occult thyroid carcinoma of the thyroid. A 'normal' finding in Finland. A systematic autopsy study. Cancer 56 531-538.
12. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR & Bergstralh EJ 1992 Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112 1139-1146.
13. Hedinger C 1988 Histological Typing of Thyroid Tumors: WHO International Histological Classification of Tumors. edn 2, Berlin, Heidelberg, New York: Springer-Verlag.
14. Hodgson NC, Button J & Solorzano CC 2004 Thyroid cancer: is the incidence still increasing? Annals of Surgical Oncology 11 1093-1097.
15. Hughes CJ, Shaha AR, Shaha JP & Loree TR 1996 Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head & Neck 18 127-132.
16. Ito Y & Miyauchi A 2007 Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits and risks. World Journal of Surgery 31 905-915.
17. Ito Y, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K & Miyauchi A 2007 Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World Journal of Surgery 31 2085-2091.
18. Kato R, Sasaki J, Kurihara H, Suzuki K, Iida Y & Kawaoi A 1992 Multiple thyroid involvement (intraglandular metastases) in papillary thyroid carcinoma: a clinicopathologic study of 105 consecutive patients. Cancer 70 1585-1590.
19. Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart JM, Travagli JP & Schlumberger M 2005 Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. Journal of Clinical Endocrinology and Metabolism 90 5723-5729.
20. Machens A, Hinze R, Thomusch O & Dralle H 2002 Pattern of nodal metastasis for primary and reoperative thyroid cancer. World Journal of Surgery 26 22-28.
21. Machens A, Holzhausen HJ & Dralle H 2005 The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. A comparative analysis. Cancer 103 2269-2273.
22. Mazzaferri EL & Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. American Journal of Medicine 97 418-428.
23. Noguchi S, Yamashita H, Murakami N, Nakayama I, Toda M & Kawamoto H 1996 Small carcinomas of the thyroid. A long-term follow-up of 867 patients. Archives of Surgery 131 187-191.
24. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JWA, Wiersinga W & the European Thyroid Cancer Taskforce 2006 European consensus for the managmenet of patients with differentiated thyroid carcinoma of the follicular epithelium. European Journal of Endocrinology 154 787-803.
25. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R & Belfiore A 2004 Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. Journal of Clinical Endocrinology and Metabolism 89 3713-3720.
26. Qubain SW, Nakano S, Baba M, Takao S & Aikou T 2002 Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 131 249-256.
27. Rossi R, Roti E, Trasforini G, Pansini G, Cavazzini L, Zatelli MC, Pearce EN, Braverman LE & Degli Uberti EC 2008 Differentiated thyroid cancers 11-20 mm in diameter have clinical and histopathologic characteristics suggesting higher aggressiveness than those ≤ 10 mm. Thyroid 18 309-315.
28. Roti E, Rossi R, Trasforini G, Bertelli F, Ambrosio MR, Busutti L, Pearce EN, Braverman LE & Degli Uberti EC 2006 Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. Journal of Clinical Endocrinology and Metabolism 91 2171-2178.
29. Sampson RJ, Woolner LB, Bahn RC & Kurland LT 1974 Occult thyroid carcinoma in Olmsted Country, Minnesota: prevalence at autopsy compared with that in Hiroshima and Nagasaki, Japan. Cancer 34 2072-2076.
30. Sawka AM, Thephamongkhol KT, Brouwers M, Thabane L, Browman G & Gerstein HC 2004 A systematic review and metaanalysis of the effectiveness of radio-active iodine remnant ablation for well-differentited thyroid cancer. Journal of Clinical Endocrinology and Metabolism 89 3668-3676.
31. Strate SM, Lee EL & Childers JH 1984 Occult papillary carcinoma of the thyroid with distant metastases. Cancer 54 1093-1100.
32. Sugitani I & Fujimoto Y 1999 Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analyses. Endocrine Journal 46 209-216.
33. Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S & Delbridge L 2006 Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140 1000-1007.
34. White ML, Gauger PG & Doherty GM 2007 Central lymph node dissection in differentiated thyroid cancer. World Journal of Surgery 31 895-904.